Online Program

Methodology for Using the Public Health Aims for Quality in Communities

Tuesday, November 3, 2015 : 10:30 a.m. - 10:45 a.m.

Rohit Ramaswamy, PhD, MPH, Public Health Leadership Program, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
The U.S. Department of Health and Human Services established 9 Public Health Aims for Quality (population-centered, equitable, proactive, health -promoting, risk-reducing, vigilant, transparent, effective, efficient) that represent criteria to measure for quality in public health programs and services. A tool based on the 9 Public Health Aims for Quality was developed to aid communities with assessing the quality of community-based programs implemented as part of the Institute for Healthcare Improvement 100 Million Healthier Lives Initiative. The tool provides a uniform set of criteria to design, assess, and monitor for quality and prioritize improvements of community health programs that is so critical to achieving overall population health improvements. The tool is modeled on a similar one successfully used for quality assessment and improvement in mobile health clinics by the Harvard Medical School Mobile Map Team and the Mobile Health Clinic Association

Learning Areas:

Conduct evaluation related to programs, research, and other areas of practice
Program planning
Public health administration or related administration
Public health or related organizational policy, standards, or other guidelines

Learning Objectives:
Describe the Public Health Aims for Quality Describe how the Public Health Quality Aims can be used to improve Community Health Programs

Keyword(s): Quality Improvement, Community Health Planning

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified given my 20 years of domestic and global experience in healthcare and public health quality
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.